A common titration approach includes: Week 12: 0.3 mg Week 34: 0.6 mg Week 56: 1.2 mg Week 78: 1.8 mg Week 9 and onward: 2.4 mg or higher, based on tolerance and clinical response Always consult a healthcare provider or licensed research facility for actual dosing guidance
Lyophilized powder remains stable for 12 to 24 months at standard refrigerator temperature
excessive activation in KCs may reduce lipid peroxidation clearance
Data were analyzed by 2-tailed t test ( B , C , E , J , K , and O ), 2-way ANOVA ( F H , I , L , and M ), and log-rank test for survival curves ( N )
the subject in need thereof may be identified as being a responder, or a subject particularly likely to benefit from treatment, based on the subject having an abnormal or poor score on at least one of the following behavioural assessments: CARS behaviour T-Score